 | • レポートコード：MRC2012A10342 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、タイサブリ（ナタリズマブ）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。タイサブリ（ナタリズマブ）薬の種類別市場規模（多発性硬化症、クローン病）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Biogen、 ・地域別グローバル市場分析 2015年-2020年 ・タイサブリ（ナタリズマブ）薬の北米市場（アメリカ、カナダ、メキシコ） ・タイサブリ（ナタリズマブ）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・タイサブリ（ナタリズマブ）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・タイサブリ（ナタリズマブ）薬の南米市場（ブラジル、アルゼンチン） ・タイサブリ（ナタリズマブ）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：多発性硬化症、クローン病 ・用途別分析：病院、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Tysabri (natalizumab) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tysabri (natalizumab) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tysabri (natalizumab) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tysabri (natalizumab) Drug market has been segmented into
Multiple Sclerosis
Crohn’s Disease
By Application, Tysabri (natalizumab) Drug has been segmented into:
Hospital
Drugs Stores
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tysabri (natalizumab) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Tysabri (natalizumab) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tysabri (natalizumab) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Tysabri (natalizumab) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tysabri (natalizumab) Drug Market Share Analysis
Tysabri (natalizumab) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tysabri (natalizumab) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tysabri (natalizumab) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Tysabri (natalizumab) Drug are:
Biogen
Among other players domestic and global, Tysabri (natalizumab) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tysabri (natalizumab) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tysabri (natalizumab) Drug, with price, sales, revenue and global market share of Tysabri (natalizumab) Drug in 2018 and 2019.
Chapter 3, the Tysabri (natalizumab) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tysabri (natalizumab) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tysabri (natalizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tysabri (natalizumab) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Tysabri (natalizumab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tysabri (natalizumab) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Multiple Sclerosis
1.2.3 Crohn’s Disease
1.3 Market Analysis by Application
1.3.1 Overview: Global Tysabri (natalizumab) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Overview of Global Tysabri (natalizumab) Drug Market
1.4.1 Global Tysabri (natalizumab) Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biogen SWOT Analysis
2.1.4 Biogen Product and Services
2.1.5 Biogen Tysabri (natalizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tysabri (natalizumab) Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tysabri (natalizumab) Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tysabri (natalizumab) Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Tysabri (natalizumab) Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tysabri (natalizumab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Tysabri (natalizumab) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tysabri (natalizumab) Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
4.3 Europe Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
4.5 South America Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tysabri (natalizumab) Drug Sales, Revenue and Market Share by Country
5.1.1 North America Tysabri (natalizumab) Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Tysabri (natalizumab) Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
5.3 Canada Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tysabri (natalizumab) Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Tysabri (natalizumab) Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tysabri (natalizumab) Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
6.3 UK Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
6.4 France Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
6.5 Russia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
6.6 Italy Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tysabri (natalizumab) Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tysabri (natalizumab) Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tysabri (natalizumab) Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
7.3 Japan Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
7.4 Korea Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
7.5 India Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
7.7 Australia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tysabri (natalizumab) Drug Sales, Revenue and Market Share by Country
8.1.1 South America Tysabri (natalizumab) Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Tysabri (natalizumab) Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tysabri (natalizumab) Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tysabri (natalizumab) Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tysabri (natalizumab) Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tysabri (natalizumab) Drug Sales and Market Share by Type (2015-2020)
10.2 Global Tysabri (natalizumab) Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Tysabri (natalizumab) Drug Price by Type (2015-2020)
11 Global Tysabri (natalizumab) Drug Market Segment by Application
11.1 Global Tysabri (natalizumab) Drug Sales Market Share by Application (2015-2020)
11.2 Global Tysabri (natalizumab) Drug Revenue Market Share by Application (2015-2020)
11.3 Global Tysabri (natalizumab) Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tysabri (natalizumab) Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Tysabri (natalizumab) Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Tysabri (natalizumab) Drug Market Forecast (2021-2025)
12.2.2 Europe Tysabri (natalizumab) Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tysabri (natalizumab) Drug Market Forecast (2021-2025)
12.2.4 South America Tysabri (natalizumab) Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tysabri (natalizumab) Drug Market Forecast (2021-2025)
12.3 Tysabri (natalizumab) Drug Market Forecast by Type (2021-2025)
12.3.1 Global Tysabri (natalizumab) Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Tysabri (natalizumab) Drug Market Share Forecast by Type (2021-2025)
12.4 Tysabri (natalizumab) Drug Market Forecast by Application (2021-2025)
12.4.1 Global Tysabri (natalizumab) Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Tysabri (natalizumab) Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tysabri (natalizumab) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tysabri (natalizumab) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tysabri (natalizumab) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Biogen Basic Information, Manufacturing Base and Competitors
Table 8. Biogen Tysabri (natalizumab) Drug Major Business
Table 9. Biogen Tysabri (natalizumab) Drug Total Revenue (USD Million) (2017-2018)
Table 10. Biogen SWOT Analysis
Table 11. Biogen Tysabri (natalizumab) Drug Product and Services
Table 12. Biogen Tysabri (natalizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Tysabri (natalizumab) Drug Sales by Manufacturer (2018-2019) (K Units)
Table 14. Global Tysabri (natalizumab) Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Tysabri (natalizumab) Drug Sales by Regions (2015-2020) (K Units)
Table 16. Global Tysabri (natalizumab) Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Tysabri (natalizumab) Drug Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Tysabri (natalizumab) Drug Sales by Countries (2015-2020) (K Units)
Table 19. North America Tysabri (natalizumab) Drug Sales Market Share by Countries (2015-2020)
Table 20. North America Tysabri (natalizumab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Tysabri (natalizumab) Drug Revenue Market Share by Countries (2015-2020)
Table 22. Europe Tysabri (natalizumab) Drug Sales by Countries (2015-2020) (K Units)
Table 23. Europe Tysabri (natalizumab) Drug Sales Market Share by Countries (2015-2020)
Table 24. Europe Tysabri (natalizumab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Tysabri (natalizumab) Drug Sales by Regions (2015-2020) (K Units)
Table 26. Asia-Pacific Tysabri (natalizumab) Drug Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Tysabri (natalizumab) Drug Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Tysabri (natalizumab) Drug Sales by Countries (2015-2020) (K Units)
Table 29. South America Tysabri (natalizumab) Drug Sales Market Share by Countries (2015-2020)
Table 30. South America Tysabri (natalizumab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Tysabri (natalizumab) Drug Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Tysabri (natalizumab) Drug Sales by Countries (2015-2020) (K Units)
Table 33. Middle East & Africa Tysabri (natalizumab) Drug Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Tysabri (natalizumab) Drug Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Tysabri (natalizumab) Drug Revenue Market Share by Countries (2015-2020)
Table 36. Global Tysabri (natalizumab) Drug Sales by Type (2015-2020) (K Units)
Table 37. Global Tysabri (natalizumab) Drug Sales Share by Type (2015-2020)
Table 38. Global Tysabri (natalizumab) Drug Revenue by Type (2015-2020) (USD Million)
Table 39. Global Tysabri (natalizumab) Drug Revenue Share by Type (2015-2020)
Table 40. Global Tysabri (natalizumab) Drug Sales by Application (2015-2020) (K Units)
Table 41. Global Tysabri (natalizumab) Drug Sales Share by Application (2015-2020)
Table 42. Global Tysabri (natalizumab) Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 43. Global Tysabri (natalizumab) Drug Market Share Forecast by Regions (2021-2025)
Table 44. Global Tysabri (natalizumab) Drug Sales Forecast by Type (2021-2025) (K Units)
Table 45. Global Tysabri (natalizumab) Drug Market Share Forecast by Type (2021-2025)
Table 46. Global Tysabri (natalizumab) Drug Sales Forecast by Application (2021-2025)
Table 47. Global Tysabri (natalizumab) Drug Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tysabri (natalizumab) Drug Picture
Figure 2. Global Sales Market Share of Tysabri (natalizumab) Drug by Type in 2019
Figure 3. Multiple Sclerosis Picture
Figure 4. Crohn's Disease Picture
Figure 5. Tysabri (natalizumab) Drug Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Drugs Stores Picture
Figure 8. Global Tysabri (natalizumab) Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Tysabri (natalizumab) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Tysabri (natalizumab) Drug Sales Market Share by Manufacturer in 2019
Figure 29. Global Tysabri (natalizumab) Drug Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Tysabri (natalizumab) Drug Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Tysabri (natalizumab) Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Tysabri (natalizumab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Tysabri (natalizumab) Drug Revenue Market Share by Regions (2015-2020)
Figure 36. Global Tysabri (natalizumab) Drug Revenue Market Share by Regions in 2018
Figure 37. North America Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
Figure 38. Europe Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
Figure 40. South America Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020)
Figure 42. North America Tysabri (natalizumab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Tysabri (natalizumab) Drug Sales Market Share by Countries (2015-2020)
Figure 44. North America Tysabri (natalizumab) Drug Sales Market Share by Countries in 2018
Figure 45. North America Tysabri (natalizumab) Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Tysabri (natalizumab) Drug Revenue Market Share by Countries in 2018
Figure 47. United States Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Tysabri (natalizumab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Tysabri (natalizumab) Drug Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Tysabri (natalizumab) Drug Revenue Market Share by Countries in 2019
Figure 53. Germany Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Tysabri (natalizumab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Tysabri (natalizumab) Drug Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Tysabri (natalizumab) Drug Revenue Market Share by Regions 2019
Figure 61. China Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Tysabri (natalizumab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Tysabri (natalizumab) Drug Sales Market Share by Countries in 2019
Figure 68. South America Tysabri (natalizumab) Drug Revenue Market Share by Countries in 2019
Figure 69. Brazil Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Tysabri (natalizumab) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Tysabri (natalizumab) Drug Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Tysabri (natalizumab) Drug Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Tysabri (natalizumab) Drug Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Tysabri (natalizumab) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Tysabri (natalizumab) Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Tysabri (natalizumab) Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Tysabri (natalizumab) Drug Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Tysabri (natalizumab) Drug Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Tysabri (natalizumab) Drug Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Tysabri (natalizumab) Drug Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Tysabri (natalizumab) Drug Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ナタリズマブ医薬品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Natalizumab Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Natalizumab Drug market repo…- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…
- タイサブリの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri market report provides a deta…
- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
- 二次性進行型多発性硬化症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Secondary Progressive Multiple Sclerosis Drug Market The global Secondary Progressive Multiple Sclerosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Secondary Progressive M…